Correlation Between Pfizer and UTA Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and UTA Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and UTA Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and UTA Acquisition Corp, you can compare the effects of market volatilities on Pfizer and UTA Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of UTA Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and UTA Acquisition.

Diversification Opportunities for Pfizer and UTA Acquisition

PfizerUTADiversified AwayPfizerUTADiversified Away100%
-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and UTA is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and UTA Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UTA Acquisition Corp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with UTA Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UTA Acquisition Corp has no effect on the direction of Pfizer i.e., Pfizer and UTA Acquisition go up and down completely randomly.

Pair Corralation between Pfizer and UTA Acquisition

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the UTA Acquisition. In addition to that, Pfizer is 11.08 times more volatile than UTA Acquisition Corp. It trades about -0.07 of its total potential returns per unit of risk. UTA Acquisition Corp is currently generating about 0.2 per unit of volatility. If you would invest  1,021  in UTA Acquisition Corp on September 19, 2024 and sell it today you would earn a total of  39.00  from holding UTA Acquisition Corp or generate 3.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy28.48%
ValuesDaily Returns

Pfizer Inc  vs.  UTA Acquisition Corp

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -15-10-50
JavaScript chart by amCharts 3.21.15PFE UTAA
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec252627282930
UTA Acquisition Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UTA Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, UTA Acquisition is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and UTA Acquisition Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-2.52-1.91-1.31-0.7-0.09420.461.041.622.22.78 51015202530
JavaScript chart by amCharts 3.21.15PFE UTAA
       Returns  

Pair Trading with Pfizer and UTA Acquisition

The main advantage of trading using opposite Pfizer and UTA Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, UTA Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UTA Acquisition will offset losses from the drop in UTA Acquisition's long position.
The idea behind Pfizer Inc and UTA Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk


 

Discover investing ideas

Utilize additional investing modules